Literature DB >> 28240435

Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.

Mark S Link1, Katy Bockstall2, Jonathan Weinstock3, Alawi A Alsheikh-Ali4, Christopher Semsarian5, N A Mark Estes3, Paolo Spirito6, Tammy S Haas7, Ethan J Rowin3, Martin S Maron3, Barry J Maron3.   

Abstract

INTRODUCTION: Triggers and ICD interventions of ventricular arrhythmias in patients with hypertrophic cardiomyopathy (HCM) offer insight into mechanisms and treatment. METHODS AND
RESULTS: Intracardiac ICD electrograms from 71 HCM patients in the HCM I and II studies were analyzed by three individuals. Rhythms were defined as VF (polymorphic ventricular arrhythmia), VT (monomorphic ventricular tachycardia), and ventricular flutter (VFL; VT ≥ 240 bpm). Physical activity and rhythm preceding the arrhythmia were ascertained. Of 149 arrhythmias, VF was present in 74, VT in 57, and VFL in 18. In those whose activity was known, moderate or intense physical activity was associated with over 50% of the tachycardias (57 of 111). Rhythms preceding ventricular arrhythmias were often sinus tachycardia (49 of 149; 33%) or rapid atrial fibrillation (7 of 149; 5%). VF and VFL were more likely preceded by supraventricular rhythms >100 bpm (30 of 68 with VF; 44%; 12 of 16 with VFL 75%, vs. 14 of 50 with VT 28%; P = 0.001). Antitachycardia pacing (ATP) was successful in 39 of 53 (74%). Multiple shocks were more often required to terminate VFL (10 of 18; 56%) compared to VF (10 of 72; 14%) and VT (2 of 25; 8%; P < 0.0001). Of arrhythmias requiring more than one shock to terminate, 16 of 22 were preceded by sinus tachycardia and/or moderate or extreme physical activity.
CONCLUSIONS: Rapid supraventricular rhythms, and at least moderate activity, frequently precede VT and VF, and when they occur in these situations often require multiple ICD shocks to restore sinus rhythm. ATP is successful in terminating VT and VFL, and should be a programmed in all HCM patients with ICDs.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  antitachycardia pacing; athletes; atrial fibrillation; exercise; hypertrophic cardiomyopathy; implantable cardioverter defibrillators; ventricular fibtillation; ventricular tachycardia

Mesh:

Year:  2017        PMID: 28240435     DOI: 10.1111/jce.13194

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  10 in total

1.  Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort Study.

Authors:  Gabrielle Norrish; Henry Chubb; Ella Field; Karen McLeod; Maria Ilina; Georgia Spentzou; Jan Till; Piers E F Daubeney; Alan Graham Stuart; Jane Matthews; Dominic Hares; Elspeth Brown; Katie Linter; Vinay Bhole; Krishnakumar Pillai; Michael Bowes; Caroline B Jones; Orhan Uzun; Amos Wong; Arthur Yue; Shankar Sadagopan; Tara Bharucha; Norah Yap; Eric Rosenthal; Sujeev Mathur; Satish Adwani; Zdenka Reinhardt; Jasveer Mangat; Juan Pablo Kaski
Journal:  Europace       Date:  2021-03-08       Impact factor: 5.214

2.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 3.  Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults.

Authors:  Paloma Jordà; Ana García-Álvarez
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

4.  Assessment of dynamic cardiac repolarization and contractility in patients with hypertrophic cardiomyopathy.

Authors:  Andrew E Radbill; Lucy Y Lei; Sachin Y Paranjape; Daniel J Blackwell; Robert L Abraham; Derek S Chew; Satish R Raj; Björn C Knollmann
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

5.  Atrial fibrillation and the risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy - A nationwide cohort study.

Authors:  Min-Tsun Liao; Cho-Kai Wu; Jyh-Ming Jimmy Juang; Ting-Tse Lin; Chih-Cheng Wu; Lian-Yu Lin
Journal:  EClinicalMedicine       Date:  2021-03-17

6.  Ventricular arrhythmia management in patients with genetic cardiomyopathies.

Authors:  Zain I Sharif; Steven A Lubitz
Journal:  Heart Rhythm O2       Date:  2021-12-17

7.  Recurrent ventricular fibrillation induced from supraventricular tachycardia in a case of hypertrophic cardiomyopathy.

Authors:  Koushik Dasgupta; Anunay Gupta; Debdatta Majumdar; Debabrata Bera
Journal:  Indian Pacing Electrophysiol J       Date:  2021-11-14

Review 8.  Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options.

Authors:  Begum Yetis Sayin; Ali Oto
Journal:  Cardiol Ther       Date:  2022-03-30

Review 9.  Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside.

Authors:  Hua Shen; Shi-Yong Dong; Ming-Shi Ren; Rong Wang
Journal:  Front Cardiovasc Med       Date:  2022-08-18

10.  Non-invasive detection of exercise-induced cardiac conduction abnormalities in sudden cardiac death survivors in the inherited cardiac conditions.

Authors:  Kevin Ming Wei Leong; Fu Siong Ng; Matthew J Shun-Shin; Michael Koa-Wing; Norman Qureshi; Zachary I Whinnett; Nick F Linton; David Lefroy; Darrel P Francis; Sian E Harding; D Wyn Davies; Nicholas S Peter; Phang Boon Lim; Elijah Behr; Pier D Lambiase; Amanda Varnava; Prapa Kanagaratnam
Journal:  Europace       Date:  2021-02-05       Impact factor: 5.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.